Shimoyama N - Search Results

1

Association between KCNJ6 (GIRK2) gene polymorphisms and postoperative analgesic requirements after major abdominal surgery.

Nishizawa D, Nagashima M, Katoh R, Satoh Y, Tagami M, Kasai S, Ogai Y, Han W, Hasegawa J, Shimoyama N, Sora I, Hayashida M, Ikeda K. Nishizawa D, et al. Among authors: shimoyama n. PLoS One. 2009 Sep 16;4(9):e7060. doi: 10.1371/journal.pone.0007060. PLoS One. 2009. PMID: 19756153 Free PMC article.

2

Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.

Yamada H, Shimoyama N, Sora I, Uhl GR, Fukuda Y, Moriya H, Shimoyama M. Yamada H, et al. Among authors: shimoyama m, shimoyama n. Brain Res. 2006 Apr 14;1083(1):61-9. doi: 10.1016/j.brainres.2006.01.095. Epub 2006 Mar 10. Brain Res. 2006. PMID: 16530171

3

Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined from oral morphine rescue doses in the treatment of breakthrough cancer pain.

Shimoyama N, Gomyo I, Teramoto O, Kojima K, Higuchi H, Yukitoshi N, Ohta E, Shimoyama M. Shimoyama N, et al. Among authors: shimoyama m. Jpn J Clin Oncol. 2015 Feb;45(2):189-96. doi: 10.1093/jjco/hyu182. Epub 2014 Nov 6. Jpn J Clin Oncol. 2015. PMID: 25378647 Clinical Trial.

4

[Treatment of constipation in chronic pain patients].

Shimoyama N, Shimoyama M. Shimoyama N, et al. Among authors: shimoyama m. Masui. 2013 Jul;62(7):822-8. Masui. 2013. PMID: 23905405 Japanese.

5

Efficacy and safety of sublingual fentanyl orally disintegrating tablet at doses determined by titration for the treatment of breakthrough pain in Japanese cancer patients: a multicenter, randomized, placebo-controlled, double-blind phase III trial.

Shimoyama N, Gomyo I, Katakami N, Okada M, Yukitoshi N, Ohta E, Shimoyama M. Shimoyama N, et al. Among authors: shimoyama m. Int J Clin Oncol. 2015 Feb;20(1):198-206. doi: 10.1007/s10147-014-0697-z. Epub 2014 May 20. Int J Clin Oncol. 2015. PMID: 24839047 Clinical Trial.

6

Differential analgesic effects of a mu-opioid peptide, [Dmt(1)]DALDA, and morphine.

Shimoyama M, Szeto HH, Schiller PW, Tagaito Y, Tokairin H, Eun Cm, Shimoyama N. Shimoyama M, et al. Among authors: shimoyama n. Pharmacology. 2009;83(1):33-7. doi: 10.1159/000167878. Epub 2008 Nov 6. Pharmacology. 2009. PMID: 18987489 Free PMC article.

7

A prospective open-label trial of gabapentin as an adjuvant analgesic with opioids for Japanese patients with neuropathic cancer pain.

Takahashi H, Shimoyama N. Takahashi H, et al. Among authors: shimoyama n. Int J Clin Oncol. 2010 Feb;15(1):46-51. doi: 10.1007/s10147-009-0009-1. Int J Clin Oncol. 2010. PMID: 20072794 Clinical Trial.

8

Differential respiratory effects of [Dmt1]DALDA and morphine in mice.

Shimoyama M, Kuwaki T, Nakamura A, Fukuda Y, Shimoyama N, Schiller PW, Szeto HH. Shimoyama M, et al. Among authors: shimoyama n. Eur J Pharmacol. 2005 Mar 28;511(2-3):199-206. doi: 10.1016/j.ejphar.2005.02.014. Eur J Pharmacol. 2005. PMID: 15792789

9

Endogenous endomorphin-2 contributes to spinal ĸ-opioid antinociception.

Shimoyama M, Toyama S, Tagaito Y, Shimoyama N. Shimoyama M, et al. Among authors: shimoyama n. Pharmacology. 2012;89(3-4):145-8. doi: 10.1159/000336770. Epub 2012 Mar 12. Pharmacology. 2012. PMID: 22414674

10

Antinociceptive and respiratory effects of intrathecal H-Tyr-D-Arg-Phe-Lys-NH2 (DALDA) and [Dmt1] DALDA.

Shimoyama M, Shimoyama N, Zhao GM, Schiller PW, Szeto HH. Shimoyama M, et al. Among authors: shimoyama n. J Pharmacol Exp Ther. 2001 Apr;297(1):364-71. J Pharmacol Exp Ther. 2001. PMID: 11259564

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

142 results

Search Page

Filters